|
1
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benderli Cihan Y: ALK inhibitors and
cranial radiotherapy in brain metastasis from NSCLC. J BUON.
23:15582018.PubMed/NCBI
|
|
3
|
Yang B, Zheng D, Zeng Υ, Qin A, Gao J and
Yu G: Circulating tumor cells predict prognosis following
secondline AZD 9291 treatment in EGFR-T790M mutant non-small cell
lung cancer patients. J BUON. 23:1077–1081. 2018.PubMed/NCBI
|
|
4
|
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L,
Zeng Y, Miao R, Jin G, Ma H, et al: Genetic variants of miRNA
sequences and non-small cell lung cancer survival. J Clin Invest.
118:2600–2608. 2008.PubMed/NCBI
|
|
5
|
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li
YJ, Yan B and Jiang Q: Pathogenic role of lncRNA-MALAT1 in
endothelial cell dysfunction in diabetes mellitus. Cell Death Dis.
5:e15062014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng N, Li X, Zhao C, Ren S, Chen X, Cai
W, Zhao M, Zhang Y, Li J, Wang Q, et al: Microarray expression
profile of long non-coding RNAs in EGFR-TKIs resistance of human
non-small cell lung cancer. Oncol Rep. 33:833–839. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vikram R, Ramachandran R and Abdul KS:
Functional significance of long non-coding RNAs in breast cancer.
Breast Cancer. 21:515–521. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding C, Yang Z, Lv Z, Du C, Xiao H, Peng
C, Cheng S, Xie H, Zhou L, Wu J, et al: Long non-coding RNA PVT1 is
associated with tumor progression and predicts recurrence in
hepatocellular carcinoma patients. Oncol Lett. 9:955–963. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS
and Feng XJ: Increased expression of the lncRNA PVT1 promotes
tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol.
7:6929–6935. 2014.PubMed/NCBI
|
|
11
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pekarsky Y, Santanam U, Cimmino A,
Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG,
Rassenti L, et al: Tcl1 expression in chronic lymphocytic leukemia
is regulated by miR-29 and miR-181. Cancer Res. 66:11590–11593.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang ZY, Fu SL, Xu SQ, Zhou X, Liu XS, Xu
YJ, Zhao JP and Wei S: By downregulating Ku80, hsa-miR-526b
suppresses non-small cell lung cancer. Oncotarget. 6:1462–1477.
2015.PubMed/NCBI
|
|
14
|
Tsang DP and Cheng AS: Epigenetic
regulation of signaling pathways in cancer: Role of the histone
methyltransferase EZH2. J Gastroenterol Hepatol. 26:19–27. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tonini T, DAndrilli G, Fucito A, Gaspa L
and Bagella L: Importance of Ezh2 polycomb protein in tumorigenesis
process interfering with the pathway of growth suppressive key
elements. J Cell Physiol. 214:295–300. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Riquelme E, Behrens C, Lin HY, Simon G,
Papadimitrakopoulou V, Izzo J, Moran C, Kalhor N, Lee JJ, Minna JD,
et al: Modulation of EZH2 expression by MEK-ERK or PI3K-AKT
signaling in lung cancer is dictated by different KRAS oncogene
mutations. Cancer Res. 76:675–685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J and Li H: CircRNA circ_0067934
silencing inhibits the proliferation, migration and invasion of
NSCLC cells and correlates with unfavorable prognosis in NSCLC. Eur
Rev Med Pharmacol Sci. 22:3053–3060. 2018.PubMed/NCBI
|
|
18
|
Yang J, Lin J, Liu T, Chen T, Pan S, Huang
W and Li S: Analysis of lncRNA expression profiles in non-small
cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer.
85:110–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei MM and Zhou GB: Long non-coding RNAs
and their roles in non-small-cell lung cancer. Genomics Proteomics
Bioinformatics. 14:280–288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu Q, Lv T, Wu Y, Shi X, Liu H and Song
Y: Long non-coding RNA 00312 regulated by HOXA5 inhibits tumour
proliferation and promotes apoptosis in non-small cell lung cancer.
J Cell Mol Med. 21:2184–2198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao
X, Chen WS and Li B: lncRNA-UCA1 exerts oncogenic functions in
non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett.
371:99–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan JJ and Tay Y: Noncoding RNA: RNA
regulatory networks in cancer. Int J Mol Sci. 19:192018. View Article : Google Scholar
|
|
23
|
Legras A, Pécuchet N, Imbeaud S, Pallier
K, Didelot A, Roussel H, Gibault L, Fabre E, Le Pimpec-Barthes F,
Laurent-Puig P, et al: Epithelial-to-mesenchymal transition and
microRNAs in lung cancer. Cancers (Basel). 9:92017. View Article : Google Scholar
|
|
24
|
Viré E, Brenner C, Deplus R, Blanchon L,
Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden
JM, et al: The Polycomb group protein EZH2 directly controls DNA
methylation. Nature. 439:871–874. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martinez-Garcia E and Licht JD:
Deregulation of H3K27 methylation in cancer. Nat Genet. 42:100–101.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Zhang H, Zhao M, Lv Z, Zhang X,
Qin X, Wang H, Wang S, Su J, Lv X, et al: MiR-138 inhibits tumor
growth through repression of EZH2 in non-small cell lung cancer.
Cell Physiol Biochem. 31:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
